The antiinfective medicine sales in Japan indicated a continuing decline from 2024 to 2028. Starting at 7.8 US Dollars PPP Per Capita in 2024, the value decreases to 6.1 by 2028. Observing the year-on-year trends, there's an approximate decline of 5.13% from 2024 to 2025, 5.41% from 2025 to 2026, 7.14% from 2026 to 2027, and 6.15% from 2027 to 2028. Compared to the 2023 value of 7.8, the average annual change (CAGR) over the five-year period showcases a steady reduction in sales, averaging a 6.18% decrease per year.
Future trends to watch for include advancements in antiinfective medicine technology, shifts in healthcare policy, and the potential impact of emerging diseases. Monitoring these factors will be crucial to anticipate changes in the market dynamics moving forward.
